To spark cancer discoveries, several Big Pharma companies are sharing idle clinical trial data

Featured Story

To spark cancer discoveries, several Big Pharma companies are sharing idle clinical trial data

April 8, 2014 7:00 am by | 1 Comments

Big Pharma spends billions of dollars each year researching, developing and testing new treatments for cancer. In the meantime, it’s also collecting millions of data points that figuratively sit on…


JNJ, BioCrossroads invest in Hoosier pharma startup at work on potential hepatitis B cure

JNJ, BioCrossroads invest in Hoosier pharma startup at work on potential hepatitis B cure

April 10, 2014 5:26 pm by | 0 Comments

An Indiana University spinout attracted investors from Johnson & Johnson Development Corp. and BioCrossroads with novel drugs to treat, and even potentially cure, patients with hepatitis B. Assembly Pharmaceuticals received an undisclosed…


Limitations imposed on use of FDA warning letters

Limitations imposed on use of FDA warning letters

March 25, 2014 10:41 pm by | 0 Comments

By Anne K. Walsh – The Supreme Court of Arkansas recently overturned (here and here) a lower court’s $1.2 billion award to the State of Arkansas, and also reversed and…



J&J takes an early interest in biotech startup Alector’s approach to Alzheimer’s treatment

J&J takes an early interest in biotech startup Alector’s approach to Alzheimer’s treatment

March 10, 2014 12:54 pm by | 0 Comments

In another move to potentially beef up its Alzheimer’s pipeline, Johnson & Johnson has struck a drug development deal with one of the companies located at its innovation lab in…


J&J and Pharmacyclics’ new chronic lymphocytic leukemia drug approved

J&J and Pharmacyclics’ new chronic lymphocytic leukemia drug approved

February 12, 2014 1:20 pm by | 0 Comments

(Reuters) – U.S. health regulators on Wednesday approved the Johnson & Johnson and Pharmacyclics Inc cancer drug Imbruvica to treat chronic lymphocytic leukemia, a slowly progressing form of blood cancer….


10 rival drug companies working together to find new drugs quicker

10 rival drug companies working together to find new drugs quicker

February 4, 2014 2:34 am by | 0 Comments

Feb 4 (Reuters) – Ten big rival drug companies have formed a pact to cooperate on a government-backed effort to accelerate the discovery of new drugs, the Wall Street Journal…


4 reasons why J&J’s agreement to share clinical trial data with Yale will help drug industry

4 reasons why J&J’s agreement to share clinical trial data with Yale will help drug industry

February 3, 2014 7:45 pm by | 2 Comments

The shift by Johnson & Johnson (NYSE: JNJ) to provide Yale University School of Medicine’s Open Data Access Project with de-identified data from clinical trials, conceived over a conversation between…


J&J chooses Yale to review requests for clinical drug data

J&J chooses Yale to review requests for clinical drug data

January 30, 2014 12:10 am by | 0 Comments

(Reuters) – Johnson & Johnson has selected the Yale School of Medicine to review requests from investigators and physicians looking for access to clinical trial data involving the diversified healthcare…



J&J ad uses sensory branding in India with the smell of baby powder

J&J ad uses sensory branding in India with the smell of baby powder

January 29, 2014 11:16 am by | 0 Comments

MUMBAI — Indian newspapers came out smelling like babies on Wednesday morning. Leading dailies such as The Times of India, The Hindu, Malayala Manorama and Mathrubhumi turned up at doorsteps…


Louisiana’s Supreme Court rules in favor of J&J in anti-psychotic drug appeal

Louisiana’s Supreme Court rules in favor of J&J in anti-psychotic drug appeal

January 28, 2014 3:23 pm by | 0 Comments

Jan 28 (Reuters) – Louisiana Supreme Court on Tuesday ruled in favor of Johnson & Johnson in an appeal related to the drugmaker’s marketing of anti-psychotic drug Risperdal, overturning a…


FDA skeptical about Johnson & Johnson’s anticoagulant Xarelto

FDA skeptical about Johnson & Johnson’s anticoagulant Xarelto

January 14, 2014 9:00 am by | 0 Comments

(Reuters) – The U.S. Food and Drug Administration appears skeptical that data submitted by Johnson & Johnson proves its anticoagulant Xarelto is effective in reducing the risk of further heart…


Swiss biotech firm AC Immune starts new Alzheimer vaccine trial

Swiss biotech firm AC Immune starts new Alzheimer vaccine trial

January 9, 2014 10:11 am by | 0 Comments

ZURICH (Reuters) – AC Immune, a privately held biotech company based in Switzerland, has launched the world’s first trial of a vaccine against a protein believed to cause Alzheimer’s after…


Johnson & Johnson appealing China for revoking diabetes trademark OneTouch

Johnson & Johnson appealing China for revoking diabetes trademark OneTouch

January 9, 2014 5:06 am by | 0 Comments

SHANGHAI (Reuters) – U.S. drugmaker Johnson & Johnson will appeal a ruling by a Chinese government agency to strip it of exclusive rights to its OneTouch trademark of diabetes monitoring…


J&J among western companies expanding production in Western China

J&J among western companies expanding production in Western China

December 28, 2013 9:30 am by | 0 Comments

BEIJING (China Daily/ANN) — Healthcare giant Johnson & Johnson Services Inc’s plan to invest US$3 billion in a new production base in Xi’an, the capital of Shaanxi province, is just the latest move among big international companies to expand in Ch…


EU a year behind U.S., but now recommends J&J’s new tuberculosis drug

EU a year behind U.S., but now recommends J&J’s new tuberculosis drug

December 20, 2013 7:18 am by | 0 Comments

LONDON (Reuters) – European regulators said on Friday they had recommended approval Johnson & Johnson’s new tuberculosis drug Sirturo, which was approved a year ago in the United States. Recommendations…


Oral leukemia treatment from J&J, Pharmacyclics gets promising news

Oral leukemia treatment from J&J, Pharmacyclics gets promising news

December 8, 2013 10:00 am by | 0 Comments

(Reuters) – A closely watched leukemia drug developed by Johnson & Johnson and Pharmacyclics Inc maintained its effectiveness in keeping the disease at bay for most patients, according to long-term…